H. Vaccine adjuvant
Open innovation among industry,
government, and academia
government, and academia
License-out strategies with global pharmaceutical companies
-
Efficacy Test
-
Toxicity Test
-
Clinical Test
Effects and advantages of adjuvant
Defense against viruses exhibited even from a small amount of antigens
① Increased antigenicity of vaccine
② Enhanced continuity of immunity
③ Reduced risk of side effects due to antig
Advantages of γ-PGA
Innocuous → Safe with no risk of side effects such as inflammation
Global market value
More than 30 vaccine adjuvants currently under development both in Korea and worldwide
Status
Open innovation among industry, government, and academia
Immunoadjuvant composition
containing γ-PGA-keto acid nanoparticles
Vaccine containing either
γ-PGA-keto acid-sM2HA2 nanoparticles or
γ-PGA-keto acid-sM2HA2CTA1 nanoparticles
γ-PGA-keto acid-sM2HA2 nanoparticles or
γ-PGA-keto acid-sM2HA2CTA1 nanoparticles
Strategy
-
2017.01
Signed the “joint R&D and material transfer contract” in 2017.01 -
2017.07
Signed the “MOU of fostering of vaccine industry and cluster activation” in 2017.07 -
“Joint research on avian influenza”
-
Enter clinical stage -
License Out to global pharm. companies